Bayer Aims to Expand HealthCare Portfolio - Analyst Blog

By
A A A

In a bid to strengthen its contraceptive portfolio Bayer ( BAYRY ) inked a deal to buy Conceptus Inc. ( CPTS ) for $31.00 per share or approximately $1.1 billion in cash. Conceptus focuses on developing and commercializing innovative device-based solutions in permanent birth control.

Bayer intends to launch a public tender offer to acquire all shares of Conceptus within the next 10 days. The transaction is expected to close by mid-2013.

Bayer's impending acquisition of Conceptus will add the Essure permanent (non-surgical) birth control system to its product portfolio. We note that Conceptus' Essure procedure was approved in 2002 in the US and is well accepted in the market. Bayer's contraceptive portfolio currently includes drugs like Yasmin/Yaz and Mirena among others.


Successful completion of the acquisition would ensure the presence of short-term, long-term and permanent contraceptive choices for women in Bayer's portfolio. The Essure procedure is a strategic fit in Bayer's HealthCare business.

Bayer mentioned in its press release that more than 700,000 women around the world have already undergone this procedure. Conceptus reported net sales of $141 million for the year 2012.

The HealthCare segment recorded revenues of €4.4 billion in the first quarter of 2013, up 2.3% year over year. Bayer expects revenues from the HealthCare segment to come in at around €19 billion in 2013.

We remind investors that the contraceptive market has players like Teva Pharmaceutical Industries Ltd. ( TEVA ).

Bayer, a large cap pharma company, presently carries a Zacks Rank #4 (Sell). Other large cap pharma companies such as Abbvie Inc. ( ABBV ) currently look more attractive. Abbvie carries a Zacks Rank #2 (Buy).



ABBVIE INC (ABBV): Free Stock Analysis Report

BAYER A G -ADR (BAYRY): Free Stock Analysis Report

CONCEPTUS INC (CPTS): Free Stock Analysis Report

TEVA PHARM ADR (TEVA): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Business , Stocks

Referenced Stocks: ABBV , BAYRY , CPTS , TEVA

Zacks.com

Zacks.com

More from Zacks.com:

Related Videos

Stocks

Referenced

Most Active by Volume

33,974,386
  • $17.98 ▲ 0.28%
20,763,901
  • $91.29 ▲ 2.06%
19,110,793
  • $7.26 ▼ 1.22%
18,528,869
    $8.33 unch
18,014,920
  • $4.19 ▼ 1.18%
16,448,919
  • $25.83 ▼ 0.19%
14,748,190
  • $7.60 ▼ 1.43%
14,144,383
  • $112.01 ▼ 0.47%
As of 12/24/2014, 02:12 PM


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com